MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cerebral palsy"

  • MDS Virtual Congress 2021

    Efficacy and safety of incobotulinumtoxinA for upper- or combined upper- and lower-limb spasticity in children/adolescents with cerebral palsy: the XARA study

    E. Dabrowski, H. Chambers, D. Gaebler-Spira, M. Banach, P. Kaňovský, A. Hanschmann, M. Althaus, T. Geister, F. Heinen (Royal Oak, USA)

    Objective: To assess the efficacy/safety of incobotulinumtoxinA for upper- and combined upper-/lower-limb spasticity in ambulant and non-ambulant children/adolescents with cerebral palsy (CP). Background: Spastic CP…
  • MDS Virtual Congress 2021

    Improvement of spasticity-related pain with incobotulinumtoxinA treatment in children/adolescents with cerebral palsy: pooled analysis of Phase 3 studies

    F. Heinen, P. Kaňovský, A. Schroeder, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M. Althaus, M. Banach, D. Gaebler-Spira (Munich, Germany)

    Objective: To assess the effect of incobotulinumtoxinA on spasticity-related pain (SRP) using pooled data from three large Phase 3 pediatric studies. Background: In children/adolescents with…
  • MDS Virtual Congress 2021

    Pooled efficacy and safety analysis of incobotulinumtoxinA for upper- and lower-limb spasticity in children with severe cerebral palsy (GMFCS levels IV–V)

    P. Kaňovský, D. Gaebler-Spira, A. Schroeder, H. Chambers, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M. Althaus, M. Banach, F. Heinen (Olomouc, Czech Republic)

    Objective: To assess the efficacy and safety of incobotulinumtoxinA for lower-limb (LL) and upper-limb (UL) spasticity in children and adolescents with cerebral palsy (CP) and…
  • MDS Virtual Congress 2020

    Cerebellar deep brain stimulation for secondary dystonia: A Case Report

    S.Z Lin, H.X Li, CC. Zhang, Y.H Wang, Y.W Wu, D.Y Li (Shanghai, China)

    Objective: To evaluate whether cerebellum deep brain stimulation (DBS) is effective in patient with secondary dystonia and to compare which target in cerebellum is more…
  • MDS Virtual Congress 2020

    Visuospatial training improved the visuospatial abilities in child with cerebral palsy: case report

    S. Kiselev (Ekaterinburg, Russian Federation)

    Objective: The goal of this study was to assess the impact of 16 weeks of visuospatial training on the visuospatial abilities in 6 years of…
  • MDS Virtual Congress 2020

    Inter-relation between hand functioning, cognition and quality of life of CP children: 2-year prospective randomized study

    T. Voloshyn, V. Kozyavkin, L. Shestopalova (Truskavets, Ukraine)

    Objective: For treatment of CP patients multidisciplinary approach is often promoted. But it is not cost-efficient to involve all medical staff and use wide variety…
  • MDS Virtual Congress 2020

    LSVT LOUD Applied to Adults with Cerebral Palsy: Two Single-Subject Studies

    G. Moya-Gale, J. Galgano, C. Ferrone, Y. Chang, G. Tsang, L. Ramig (Brooklyn, NY, USA)

    Objective: To examine treatment-related acoustic and perceptual changes after LSVT LOUD ® in two adult speakers with dysarthria secondary to cerebral palsy (CP). Background: Cerebral…
  • MDS Virtual Congress 2020

    Effects of maximum speed treadmill training on walking capability in children with cerebral palsy

    N. Thawinchai (Muang Chiang Mai, Thailand)

    Objective: To examine effects of treadmill training on gross motor skills, ability to walk up-down stairs and on level ground, maximum voluntary isometric contraction force…
  • 2019 International Congress

    Modern aspects of genetics of child cerebral palsy with symptomatic epilepsy

    D. Aminova (Tashkent, Uzbekistan)

    Objective: Objective of the study was the molecular genetic aspects of child cerebral palsy and symptomatic epilepsy in children. Background: From a genetic point of…
  • 2019 International Congress

    Cerebral palsy masqueraders in an adult movement disorder tertiary centre: when to investigate an alternative diagnosis?

    S. Duarte, R. Martins, M. Magalhães (Porto, Portugal)

    Objective: Revisit cerebral palsy (CP) cases referred to an adult movement disorder tertiary centre. Background: CP is an umbrella term that defines a group of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley